ACRO

ACRO

制药业

Washington,District of Columbia 11,587 位关注者

Representing the Global Clinical Research Industry

关于我们

ACRO advocates as the collective voice of innovative clinical research and technology organizations to regulators and policymakers, educating stakeholders and shaping policies that foster efficient, effective, and safe conduct of clinical research. Since our founding in 2002, ACRO has been committed to strengthening public understanding and confidence in clinical research. ACRO’s membership has evolved from being comprised entirely of global CROs to now including several of the industry’s technology partners. ACRO looks to demonstrate the important contribution that CROs and technology companies make as partners in the development of new medicines and new treatments. The association is a leading voice for safe and ethical clinical trials, working with stakeholders globally to explore new paradigms for research and development and to promote a more innovative, safe, and efficient clinical trial process. As an association, we are especially interested in areas such as the expansion of the adoption of DCTs, RBQM, diversity and inclusion in clinical trials, enhancing the efficiency of R&D, data sharing, data protection and privacy, technology innovation, real-world evidence, patient-centered drug development, safety and ethics in clinical research, tax policies that support research and innovation, and a host of global regulatory issues.

网站
https://acrohealth.org/
所属行业
制药业
规模
2-10 人
总部
Washington,District of Columbia
类型
私人持股
创立
2002
领域
Clinical Research、Clinical Trials、CRO、Biomedical Research和health

地点

  • 主要

    601 New Jersey Ave NW

    Suite 350

    US,District of Columbia,Washington,20001

    获取路线

ACRO员工

动态

相似主页

查看职位